Pfizer Limited announced the appointment of Meenakshi Nevatia as an Additional Director and the Managing Director for a period of five years with effect from 3rd April 2023. She succeeds S Sridhar, who announced his early retirement in August 2022, according to ETHRWorld report.
Meenakshi is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and more recently with Stryker Corporation.
Meenakshi has worked in over 8 countries (developed and emerging) and has held several General Management roles across multiple markets such as Thailand, Spain (Iberia) and India.
The Board of Directors of Pfizer Limited, at their meeting held on 9th February 2023, considered the recommendation of the Nomination & Remuneration Committee, and approved the appointment of Meenakshi as the Managing Director w.e.f. 3rd April 2023.
S. Sridhar the current India Country President will be stepping down as Managing Director and Member of Board close of business hours on 31st March 2023.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.